APO Research, Inc.
Talk to an analyst

APO RESEARCH · REPORT

Human Blood Products

Compare research editions
View pricing & licenses

Selected research

Market Outlook & Growth Opportunities

Global Human Blood Products Market Outlook and Growth Opportunities 2026

Report ID 173999520430 December 2025202 pages

Choose your research edition.

Industry ResearchHuman Blood Products Industry Research Report 2026133 pages · $2,950 USDIndustry Growth & TrendsGlobal Human Blood Products Industry Growth and Trends Forecast to 2032112 pages · $3,450 USDMarket StructureGlobal Human Blood Products Market by Size, by Type, by Application, by Region, History and Forecast 2021-2032195 pages · $3,950 USDMarket Outlook & Growth OpportunitiesGlobal Human Blood Products Market Outlook and Growth Opportunities 2026202 pages · $4,250 USDMarket Analysis & ForecastGlobal Human Blood Products Market Analysis and Forecast 2026-2032203 pages · $4,950 USD

Market perspective

The global Human Blood Products market was valued at US$ million in 2026 and is projected to reach US$ million by 2032, implying a compound annual growth rate (CAGR) of % over 2026-2032.

The North America market for Human Blood Products is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.

The Europe market for Human Blood Products is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.

Read the full market overview

The Asia Pacific market for Human Blood Products is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.

In China, the Human Blood Products market is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.

Major global companies in the Human Blood Products market include Biotest, BPL, CSL, Grifols, Kedrion, KM Biologics, LFB Group, Octapharma and Boya Bio, among others. In 2025, the top three vendors together accounted for approximately % of global market revenue.

This report provides an overview of the global Human Blood Products market in terms of revenue and gross margin, analyzing global market trends using historical revenue data for 2021-2025, estimates for 2026, and projected CAGRs through 2032.

The study covers key producers of Human Blood Products and market revenue by major regions and countries, assesses future market potential, and highlights priority regions and countries for segmenting the market into sub-sectors, with country-specific market value data for the U.S., Canada, Mexico, Brazil, China, Japan, South Korea, Southeast Asia, India, Germany, the U.K., Italy, the Middle East, Africa, and other countries.

The report also presents Human Blood Products revenue, market share, and industry ranking for the main companies for 2021-2026, identifies the major stakeholders in the global market, and analyzes their competitive landscape and market positioning based on recent developments and segmental revenues.

Across the 2021-2026 period, the analysis compares revenue growth and profitability profiles by company, distinguishing participants with sustained expansion from those with more cyclical performance, and relates these patterns to differences in regional exposure, product portfolios, and application focus in the global Human Blood Products market.

Human Blood Products Segment by Company

Biotest

BPL

CSL

Grifols

Kedrion

KM Biologics

LFB Group

Octapharma

Boya Bio

Hualan Bio

Nanyue Bio

RAAS

Shuanglin Bio

CBPO

Tiantan Bio

Weiguang Bio

Takeda

Yuanda Shuyang

Human Blood Products Segment by Type

Immune Globulin

Coagulation Factor

Albumin

Other

Human Blood Products Segment by Application

Hospital

Retail Pharmacy

Other

Human Blood Products Segment by Region

North America

United States

Canada

Europe

Germany

France

U.K.

Italy

Netherlands

Asia-Pacific

China

Japan

South Korea

India

Australia

China Taiwan

Southeast Asia

South America

Mexico

Brazil

Argentina

Middle East & Africa

Turkey

Saudi Arabia

UAE

Study Objectives

1. To analyze and research the global Human Blood Products status and future forecast, involving, revenue, growth rate (CAGR), market share, historical and forecast.

2. To present the Human Blood Products key companies, revenue, market share, and recent developments.

3. To split the Human Blood Products breakdown data by regions, type, companies, and application.

4. To analyze the global and key regions Human Blood Products market potential and advantage, opportunity and challenge, restraints, and risks.

5. To identify Human Blood Products significant trends, drivers, influence factors in global and regions.

6. To analyze Human Blood Products competitive developments such as expansions, agreements, new product launches, and acquisitions in the market.

Reasons to Buy This Report

1. This report will help the readers to understand the competition within the industries and strategies for the competitive environment to enhance the potential profit. The report also focuses on the competitive landscape of the global Human Blood Products market, and introduces in detail the market share, industry ranking, competitor ecosystem, market performance, new product development, operation situation, expansion, and acquisition. etc. of the main players, which helps the readers to identify the main competitors and deeply understand the competition pattern of the market.

2. This report will help stakeholders to understand the global industry status and trends of Human Blood Products and provides them with information on key market drivers, restraints, challenges, and opportunities.

3. This report will help stakeholders to understand competitors better and gain more insights to strengthen their position in their businesses. The competitive landscape section includes the market share and rank (in sales and value), competitor ecosystem, new product development, expansion, and acquisition.

4. This report stays updated with novel technology integration, features, and the latest developments in the market.

5. This report helps stakeholders to gain insights into which regions to target globally.

6. This report helps stakeholders to gain insights into the end-user perception concerning the adoption of Human Blood Products.

7. This report helps stakeholders to identify some of the key players in the market and understand their valuable contribution.

Chapter Outline

Chapter 1: Introduces the report scope of the report, global total market size.

Chapter 2: Analysis key trends, drivers, challenges, and opportunities within the global Human Blood Products industry.

Chapter 3: Detailed analysis of Human Blood Products company competitive landscape, revenue market share, latest development plan, merger, and acquisition information, etc.

Chapter 4: Provides the analysis of various market segments by type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.

Chapter 5: Provides the analysis of various market segments by application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.

Chapter 6: Sales value of Human Blood Products in regional level. It provides a quantitative analysis of the market size and development potential of each region and introduces the market development, future development prospects, market space, and market size of key country in the world.

Chapter 7: Sales value of Human Blood Products in country level. It provides sigmate data by type, and by application for each country/region.

Chapter 8: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including revenue, gross margin, product introduction, recent development, etc.

Chapter 9: Concluding Insights.

More report detail

Tables and figures
List of Tables Table 1. Human Blood Products Industry Trends Table 2. Human Blood Products Industry Drivers Table 3. Human Blood Products Industry Opportunities and Challenges Table 4. Human Blood Products Industry Restraints Table 5. Global Human Blood Products Revenue by Company (US$ Million) & (2021-2026) Table 6. Global Human Blood Products Revenue Share by Company (2021-2026) Table 7. Global Human Blood Products Company Ranking, (2024-2026) & (US$ Million) Table 8. Global Human Blood Products Key Company Manufacturing Base & Headquarters Table 9. Global Human Blood Products Company, Product Type & Application Table 10. Global Human Blood Products Company Establishment Date Table 11. Global Company Market Concentration Ratio (CR5 and HHI) Table 12. Global Human Blood Products by Company Type (Tier 1, Tier 2, and Tier 3) & (Based on Revenue of 2025) Table 13. Mergers & Acquisitions, Expansion Table 14. Significant Companies of Immune Globulin Table 15. Significant Companies of Coagulation Factor Table 16. Significant Companies of Albumin Table 17. Significant Companies of Other Table 18. Global Human Blood Products Sales Value by Type 2021 VS 2025 VS 2032 (US$ Million) Table 19. Global Human Blood Products Sales Value by Type (2021-2026) & (US$ Million) Table 20. Global Human Blood Products Sales Value by Type (2027-2032) & (US$ Million) Table 21. Global Human Blood Products Sales Value Share by Type (2021-2026) Table 22. Global Human Blood Products Sales Value Share by Type (2027-2032) Table 23. Significant Companies of Hospital Table 24. Significant Companies of Retail Pharmacy Table 25. Significant Companies of Other Table 26. Global Human Blood Products Sales Value by Application 2021 VS 2025 VS 2032 (US$ Million) Table 27. Global Human Blood Products Sales Value by Application (2021-2026) & (US$ Million) Table 28. Global Human Blood Products Sales Value by Application (2027-2032) & (US$ Million) Table 29. Global Human Blood Products Sales Value Share by Application (2021-2026) Table 30. Global Human Blood Products Sales Value Share by Application (2027-2032) Table 31. Global Human Blood Products Sales Value Comparison by Region: 2021 VS 2025 VS 2032 (US$ Million) Table 32. Global Human Blood Products Sales Value by Region (2021-2026) & (US$ Million) Table 33. Global Human Blood Products Sales Value Share by Region (2021-2026) Table 34. Global Human Blood Products Sales Value by Region (2027-2032) & (US$ Million) Table 35. Global Human Blood Products Sales Value Share by Region (2027-2032) Table 36. Global Human Blood Products Sales Value by Country: 2021 VS 2025 VS 2032 (US$ Million) Table 37. Global Human Blood Products Sales Value by Country (2021-2026) & (US$ Million) Table 38. Global Human Blood Products Sales Value Market Share by Country (2021-2026) Table 39. Global Human Blood Products Sales Value by Country (2027-2032) & (US$ Million) Table 40. Global Human Blood Products Sales Value Market Share by Country (2027-2032) Table 41. Biotest Company Information Table 42. Biotest Business Overview Table 43. Biotest Human Blood Products Revenue (US$ Million) and Gross Margin (2021-2026) Table 44. Biotest Human Blood Products Product Portfolio Table 45. Biotest Recent Development Table 46. BPL Company Information Table 47. BPL Business Overview Table 48. BPL Human Blood Products Revenue (US$ Million) and Gross Margin (2021-2026) Table 49. BPL Human Blood Products Product Portfolio Table 50. BPL Recent Development Table 51. CSL Company Information Table 52. CSL Business Overview Table 53. CSL Human Blood Products Revenue (US$ Million) and Gross Margin (2021-2026) Table 54. CSL Human Blood Products Product Portfolio Table 55. CSL Recent Development Table 56. Grifols Company Information Table 57. Grifols Business Overview Table 58. Grifols Human Blood Products Revenue (US$ Million) and Gross Margin (2021-2026) Table 59. Grifols Human Blood Products Product Portfolio Table 60. Grifols Recent Development Table 61. Kedrion Company Information Table 62. Kedrion Business Overview Table 63. Kedrion Human Blood Products Revenue (US$ Million) and Gross Margin (2021-2026) Table 64. Kedrion Human Blood Products Product Portfolio Table 65. Kedrion Recent Development Table 66. KM Biologics Company Information Table 67. KM Biologics Business Overview Table 68. KM Biologics Human Blood Products Revenue (US$ Million) and Gross Margin (2021-2026) Table 69. KM Biologics Human Blood Products Product Portfolio Table 70. KM Biologics Recent Development Table 71. LFB Group Company Information Table 72. LFB Group Business Overview Table 73. LFB Group Human Blood Products Revenue (US$ Million) and Gross Margin (2021-2026) Table 74. LFB Group Human Blood Products Product Portfolio Table 75. LFB Group Recent Development Table 76. Octapharma Company Information Table 77. Octapharma Business Overview Table 78. Octapharma Human Blood Products Revenue (US$ Million) and Gross Margin (2021-2026) Table 79. Octapharma Human Blood Products Product Portfolio Table 80. Octapharma Recent Development Table 81. Boya Bio Company Information Table 82. Boya Bio Business Overview Table 83. Boya Bio Human Blood Products Revenue (US$ Million) and Gross Margin (2021-2026) Table 84. Boya Bio Human Blood Products Product Portfolio Table 85. Boya Bio Recent Development Table 86. Hualan Bio Company Information Table 87. Hualan Bio Business Overview Table 88. Hualan Bio Human Blood Products Revenue (US$ Million) and Gross Margin (2021-2026) Table 89. Hualan Bio Human Blood Products Product Portfolio Table 90. Hualan Bio Recent Development Table 91. Nanyue Bio Company Information Table 92. Nanyue Bio Business Overview Table 93. Nanyue Bio Human Blood Products Sales (K Units), Value (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 94. Nanyue Bio Human Blood Products Product Portfolio Table 95. Nanyue Bio Recent Development Table 96. RAAS Company Information Table 97. RAAS Business Overview Table 98. RAAS Human Blood Products Sales (K Units), Value (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 99. RAAS Human Blood Products Product Portfolio Table 100. RAAS Recent Development Table 101. Shuanglin Bio Company Information Table 102. Shuanglin Bio Business Overview Table 103. Shuanglin Bio Human Blood Products Sales (K Units), Value (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 104. Shuanglin Bio Human Blood Products Product Portfolio Table 105. Shuanglin Bio Recent Development Table 106. CBPO Company Information Table 107. CBPO Business Overview Table 108. CBPO Human Blood Products Sales (K Units), Value (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 109. CBPO Human Blood Products Product Portfolio Table 110. CBPO Recent Development Table 111. Tiantan Bio Company Information Table 112. Tiantan Bio Business Overview Table 113. Tiantan Bio Human Blood Products Sales (K Units), Value (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 114. Tiantan Bio Human Blood Products Product Portfolio Table 115. Tiantan Bio Recent Development Table 116. Weiguang Bio Company Information Table 117. Weiguang Bio Business Overview Table 118. Weiguang Bio Human Blood Products Sales (K Units), Value (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 119. Weiguang Bio Human Blood Products Product Portfolio Table 120. Weiguang Bio Recent Development Table 121. Takeda Company Information Table 122. Takeda Business Overview Table 123. Takeda Human Blood Products Sales (K Units), Value (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 124. Takeda Human Blood Products Product Portfolio Table 125. Takeda Recent Development Table 126. Yuanda Shuyang Company Information Table 127. Yuanda Shuyang Business Overview Table 128. Yuanda Shuyang Human Blood Products Sales (K Units), Value (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 129. Yuanda Shuyang Human Blood Products Product Portfolio Table 130. Yuanda Shuyang Recent Development Table 131. Research Programs/Design for This Report Table 132. Authors List of This Report Table 133. Secondary Sources Table 134. Primary Sources List of Figures Figure 1. Human Blood Products Product Image Figure 2. Global Human Blood Products Market Size (US$ Million), 2021 VS 2025 VS 2032 Figure 3. Global Human Blood Products Market Size (2021-2032) & (US$ Million) Figure 4. Global Human Blood Products Company Revenue Ranking in 2025 (US$ Million) Figure 5. Global Top 5 and 10 Company Market Share by Revenue in 2025 (US$ Million) Figure 6. Company Type (Tier 1, Tier 2, and Tier 3): 2021 VS 2025 Figure 7. Immune Globulin Image Figure 8. Coagulation Factor Image Figure 9. Albumin Image Figure 10. Other Image Figure 11. Global Human Blood Products Sales Value by Type (2021 VS 2025 VS 2032) & (US$ Million) Figure 12. Global Human Blood Products Sales Value Share 2021 VS 2025 VS 2032 Figure 13. Global Human Blood Products Sales Value Share by Type (2021-2032) Figure 14. Hospital Image Figure 15. Retail Pharmacy Image Figure 16. Other Image Figure 17. Global Human Blood Products Sales Value by Application (2021 VS 2025 VS 2032) & (US$ Million) Figure 18. Global Human Blood Products Sales Value Share 2021 VS 2025 VS 2032 Figure 19. Global Human Blood Products Sales Value Share by Application (2021-2032) Figure 20. Global Human Blood Products Sales Value Comparison by Region: 2021 VS 2025 VS 2032 (US$ Million) Figure 21. Global Human Blood Products Sales Value Share by Region: 2021 VS 2025 VS 2032 Figure 22. North America Human Blood Products Sales Value (2021-2032) & (US$ Million) Figure 23. North America Human Blood Products Sales Value Share by Country (%), 2025 VS 2032 Figure 24. Europe Human Blood Products Sales Value (2021-2032) & (US$ Million) Figure 25. Europe Human Blood Products Sales Value Share by Country (%), 2025 VS 2032 Figure 26. Asia-Pacific Human Blood Products Sales Value (2021-2032) & (US$ Million) Figure 27. Asia-Pacific Human Blood Products Sales Value Share by Country (%), 2025 VS 2032 Figure 28. South America Human Blood Products Sales Value (2021-2032) & (US$ Million) Figure 29. South America Human Blood Products Sales Value Share by Country (%), 2025 VS 2032 Figure 30. Middle East & Africa Human Blood Products Sales Value (2021-2032) & (US$ Million) Figure 31. Middle East & Africa Human Blood Products Sales Value Share by Country (%), 2025 VS 2032 Figure 32. USA Human Blood Products Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 33. USA Human Blood Products Sales Value Share by Type, 2025 VS 2032 & (%) Figure 34. USA Human Blood Products Sales Value Share by Application, 2025 VS 2032 & (%) Figure 35. Canada Human Blood Products Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 36. Canada Human Blood Products Sales Value Share by Type, 2025 VS 2032 & (%) Figure 37. Canada Human Blood Products Sales Value Share by Application, 2025 VS 2032 & (%) Figure 38. Mexico Human Blood Products Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 39. Mexico Human Blood Products Sales Value Share by Type, 2025 VS 2032 & (%) Figure 40. Mexico Human Blood Products Sales Value Share by Application, 2025 VS 2032 & (%) Figure 41. Germany Human Blood Products Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 42. Germany Human Blood Products Sales Value Share by Type, 2025 VS 2032 & (%) Figure 43. Germany Human Blood Products Sales Value Share by Application, 2025 VS 2032 & (%) Figure 44. France Human Blood Products Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 45. France Human Blood Products Sales Value Share by Type, 2025 VS 2032 & (%) Figure 46. France Human Blood Products Sales Value Share by Application, 2025 VS 2032 & (%) Figure 47. U.K. Human Blood Products Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 48. U.K. Human Blood Products Sales Value Share by Type, 2025 VS 2032 & (%) Figure 49. U.K. Human Blood Products Sales Value Share by Application, 2025 VS 2032 & (%) Figure 50. Italy Human Blood Products Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 51. Italy Human Blood Products Sales Value Share by Type, 2025 VS 2032 & (%) Figure 52. Italy Human Blood Products Sales Value Share by Application, 2025 VS 2032 & (%) Figure 53. Spain Human Blood Products Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 54. Spain Human Blood Products Sales Value Share by Type, 2025 VS 2032 & (%) Figure 55. Spain Human Blood Products Sales Value Share by Application, 2025 VS 2032 & (%) Figure 56. Russia Human Blood Products Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 57. Russia Human Blood Products Sales Value Share by Type, 2025 VS 2032 & (%) Figure 58. Russia Human Blood Products Sales Value Share by Application, 2025 VS 2032 & (%) Figure 59. Netherlands Human Blood Products Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 60. Netherlands Human Blood Products Sales Value Share by Type, 2025 VS 2032 & (%) Figure 61. Netherlands Human Blood Products Sales Value Share by Application, 2025 VS 2032 & (%) Figure 62. Nordic Countries Human Blood Products Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 63. Nordic Countries Human Blood Products Sales Value Share by Type, 2025 VS 2032 & (%) Figure 64. Nordic Countries Human Blood Products Sales Value Share by Application, 2025 VS 2032 & (%) Figure 65. China Human Blood Products Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 66. China Human Blood Products Sales Value Share by Type, 2025 VS 2032 & (%) Figure 67. China Human Blood Products Sales Value Share by Application, 2025 VS 2032 & (%) Figure 68. Japan Human Blood Products Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 69. Japan Human Blood Products Sales Value Share by Type, 2025 VS 2032 & (%) Figure 70. Japan Human Blood Products Sales Value Share by Application, 2025 VS 2032 & (%) Figure 71. South Korea Human Blood Products Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 72. South Korea Human Blood Products Sales Value Share by Type, 2025 VS 2032 & (%) Figure 73. South Korea Human Blood Products Sales Value Share by Application, 2025 VS 2032 & (%) Figure 74. India Human Blood Products Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 75. India Human Blood Products Sales Value Share by Type, 2025 VS 2032 & (%) Figure 76. India Human Blood Products Sales Value Share by Application, 2025 VS 2032 & (%) Figure 77. Australia Human Blood Products Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 78. Australia Human Blood Products Sales Value Share by Type, 2025 VS 2032 & (%) Figure 79. Australia Human Blood Products Sales Value Share by Application, 2025 VS 2032 & (%) Figure 80. Southeast Asia Human Blood Products Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 81. Southeast Asia Human Blood Products Sales Value Share by Type, 2025 VS 2032 & (%) Figure 82. Southeast Asia Human Blood Products Sales Value Share by Application, 2025 VS 2032 & (%) Figure 83. Brazil Human Blood Products Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 84. Brazil Human Blood Products Sales Value Share by Type, 2025 VS 2032 & (%) Figure 85. Brazil Human Blood Products Sales Value Share by Application, 2025 VS 2032 & (%) Figure 86. Argentina Human Blood Products Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 87. Argentina Human Blood Products Sales Value Share by Type, 2025 VS 2032 & (%) Figure 88. Argentina Human Blood Products Sales Value Share by Application, 2025 VS 2032 & (%) Figure 89. Chile Human Blood Products Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 90. Chile Human Blood Products Sales Value Share by Type, 2025 VS 2032 & (%) Figure 91. Chile Human Blood Products Sales Value Share by Application, 2025 VS 2032 & (%) Figure 92. Colombia Human Blood Products Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 93. Colombia Human Blood Products Sales Value Share by Type, 2025 VS 2032 & (%) Figure 94. Colombia Human Blood Products Sales Value Share by Application, 2025 VS 2032 & (%) Figure 95. Peru Human Blood Products Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 96. Peru Human Blood Products Sales Value Share by Type, 2025 VS 2032 & (%) Figure 97. Peru Human Blood Products Sales Value Share by Application, 2025 VS 2032 & (%) Figure 98. Saudi Arabia Human Blood Products Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 99. Saudi Arabia Human Blood Products Sales Value Share by Type, 2025 VS 2032 & (%) Figure 100. Saudi Arabia Human Blood Products Sales Value Share by Application, 2025 VS 2032 & (%) Figure 101. Israel Human Blood Products Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 102. Israel Human Blood Products Sales Value Share by Type, 2025 VS 2032 & (%) Figure 103. Israel Human Blood Products Sales Value Share by Application, 2025 VS 2032 & (%) Figure 104. UAE Human Blood Products Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 105. UAE Human Blood Products Sales Value Share by Type, 2025 VS 2032 & (%) Figure 106. UAE Human Blood Products Sales Value Share by Application, 2025 VS 2032 & (%) Figure 107. Turkey Human Blood Products Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 108. Turkey Human Blood Products Sales Value Share by Type, 2025 VS 2032 & (%) Figure 109. Turkey Human Blood Products Sales Value Share by Application, 2025 VS 2032 & (%) Figure 110. Iran Human Blood Products Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 111. Iran Human Blood Products Sales Value Share by Type, 2025 VS 2032 & (%) Figure 112. Iran Human Blood Products Sales Value Share by Application, 2025 VS 2032 & (%) Figure 113. Egypt Human Blood Products Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 114. Egypt Human Blood Products Sales Value Share by Type, 2025 VS 2032 & (%) Figure 115. Egypt Human Blood Products Sales Value Share by Application, 2025 VS 2032 & (%) Figure 116. Years Considered Figure 117. Research Process Figure 118. Key Executives Interviewed

Scope & coverage.

Types
  • Immune Globulin
  • Coagulation Factor
  • Albumin
  • Other
Applications
  • Hospital
  • Retail Pharmacy
  • Other
Companies covered
  • Biotest
  • BPL
  • CSL
  • Grifols
  • Kedrion
  • KM Biologics
  • LFB Group
  • Octapharma
  • Boya Bio
  • Hualan Bio
  • Nanyue Bio
  • RAAS
  • Shuanglin Bio
  • CBPO
  • Tiantan Bio
  • Weiguang Bio
  • Takeda
  • Yuanda Shuyang

Inside the report.

1 Market Overview
  1. 1.1 Product Definition
  2. 1.2 Global Human Blood Products Market Size, 2021 VS 2025 VS 2032
  3. 1.3 Global Human Blood Products Market Size (2021-2032)
  4. 1.4 Assumptions and Limitations
  5. 1.5 Study Goals and Objectives
2 Human Blood Products Market Dynamics
  1. 2.1 Human Blood Products Industry Trends
  2. 2.2 Human Blood Products Industry Drivers
  3. 2.3 Human Blood Products Industry Opportunities and Challenges
  4. 2.4 Human Blood Products Industry Restraints
3 Human Blood Products Market by Company
  1. 3.1 Global Human Blood Products Company Revenue Ranking in 2025
  2. 3.2 Global Human Blood Products Revenue by Company (2021-2026)
  3. 3.3 Global Human Blood Products Company Ranking (2024-2026)
  4. 3.4 Global Human Blood Products Company Manufacturing Base and Headquarters
  5. 3.5 Global Human Blood Products Company Product Type and Application
  6. 3.6 Global Human Blood Products Company Establishment Date
  7. 3.7 Market Competitive Analysis
  8. 3.7.1 Global Human Blood Products Market Concentration Ratio (CR5 and HHI)
  9. 3.7.2 Global Top 5 and 10 Company Market Share by Revenue in 2025
  10. 3.7.3 2025 Human Blood Products Tier 1, Tier 2, and Tier 3 Companies
  11. 3.8 Mergers and Acquisitions Expansion
4 Human Blood Products Market by Type
  1. 4.1 Human Blood Products Type Introduction
  2. 4.1.1 Immune Globulin
  3. 4.1.2 Coagulation Factor
  4. 4.1.3 Albumin
  5. 4.1.4 Other
  6. 4.2 Global Human Blood Products Sales Value by Type
  7. 4.2.1 Global Human Blood Products Sales Value by Type (2021 VS 2025 VS 2032)
  8. 4.2.2 Global Human Blood Products Sales Value by Type (2021-2032)
  9. 4.2.3 Global Human Blood Products Sales Value Share by Type (2021-2032)
5 Human Blood Products Market by Application
  1. 5.1 Human Blood Products Application Introduction
  2. 5.1.1 Hospital
  3. 5.1.2 Retail Pharmacy
  4. 5.1.3 Other
  5. 5.2 Global Human Blood Products Sales Value by Application
  6. 5.2.1 Global Human Blood Products Sales Value by Application (2021 VS 2025 VS 2032)
  7. 5.2.2 Global Human Blood Products Sales Value by Application (2021-2032)
  8. 5.2.3 Global Human Blood Products Sales Value Share by Application (2021-2032)
6 Human Blood Products Regional Value Analysis
  1. 6.1 Global Human Blood Products Sales Value by Region: 2021 VS 2025 VS 2032
  2. 6.2 Global Human Blood Products Sales Value by Region (2021-2032)
  3. 6.2.1 Global Human Blood Products Sales Value by Region: 2021-2026
  4. 6.2.2 Global Human Blood Products Sales Value by Region (2027-2032)
  5. 6.3 North America
  6. 6.3.1 North America Human Blood Products Sales Value (2021-2032)
  7. 6.3.2 North America Human Blood Products Sales Value Share by Country, 2025 VS 2032
  8. 6.4 Europe
  9. 6.4.1 Europe Human Blood Products Sales Value (2021-2032)
  10. 6.4.2 Europe Human Blood Products Sales Value Share by Country, 2025 VS 2032
  11. 6.5 Asia-Pacific
  12. 6.5.1 Asia-Pacific Human Blood Products Sales Value (2021-2032)
  13. 6.5.2 Asia-Pacific Human Blood Products Sales Value Share by Country, 2025 VS 2032
  14. 6.6 South America
  15. 6.6.1 South America Human Blood Products Sales Value (2021-2032)
  16. 6.6.2 South America Human Blood Products Sales Value Share by Country, 2025 VS 2032
  17. 6.7 Middle East & Africa
  18. 6.7.1 Middle East & Africa Human Blood Products Sales Value (2021-2032)
  19. 6.7.2 Middle East & Africa Human Blood Products Sales Value Share by Country, 2025 VS 2032
7 Human Blood Products Country-level Value Analysis
  1. 7.1 Global Human Blood Products Sales Value by Country: 2021 VS 2025 VS 2032
  2. 7.2 Global Human Blood Products Sales Value by Country (2021-2032)
  3. 7.2.1 Global Human Blood Products Sales Value by Country (2021-2026)
  4. 7.2.2 Global Human Blood Products Sales Value by Country (2027-2032)
  5. 7.3 USA
  6. 7.3.1 USA Human Blood Products Sales Value Growth Rate (2021-2032)
  7. 7.3.2 USA Human Blood Products Sales Value Share by Type, 2025 VS 2032
  8. 7.3.3 USA Human Blood Products Sales Value Share by Application, 2025 VS 2032
  9. 7.4 Canada
  10. 7.4.1 Canada Human Blood Products Sales Value Growth Rate (2021-2032)
  11. 7.4.2 Canada Human Blood Products Sales Value Share by Type, 2025 VS 2032
  12. 7.4.3 Canada Human Blood Products Sales Value Share by Application, 2025 VS 2032
  13. 7.5 Mexico
  14. 7.5.1 Mexico Human Blood Products Sales Value Growth Rate (2021-2032)
  15. 7.5.2 Mexico Human Blood Products Sales Value Share by Type, 2025 VS 2032
  16. 7.5.3 Mexico Human Blood Products Sales Value Share by Application, 2025 VS 2032
  17. 7.6 Germany
  18. 7.6.1 Germany Human Blood Products Sales Value Growth Rate (2021-2032)
  19. 7.6.2 Germany Human Blood Products Sales Value Share by Type, 2025 VS 2032
  20. 7.6.3 Germany Human Blood Products Sales Value Share by Application, 2025 VS 2032
  21. 7.7 France
  22. 7.7.1 France Human Blood Products Sales Value Growth Rate (2021-2032)
  23. 7.7.2 France Human Blood Products Sales Value Share by Type, 2025 VS 2032
  24. 7.7.3 France Human Blood Products Sales Value Share by Application, 2025 VS 2032
  25. 7.8 U.K.
  26. 7.8.1 U.K. Human Blood Products Sales Value Growth Rate (2021-2032)
  27. 7.8.2 U.K. Human Blood Products Sales Value Share by Type, 2025 VS 2032
  28. 7.8.3 U.K. Human Blood Products Sales Value Share by Application, 2025 VS 2032
  29. 7.9 Italy
  30. 7.9.1 Italy Human Blood Products Sales Value Growth Rate (2021-2032)
  31. 7.9.2 Italy Human Blood Products Sales Value Share by Type, 2025 VS 2032
  32. 7.9.3 Italy Human Blood Products Sales Value Share by Application, 2025 VS 2032
  33. 7.10 Spain
  34. 7.10.1 Spain Human Blood Products Sales Value Growth Rate (2021-2032)
  35. 7.10.2 Spain Human Blood Products Sales Value Share by Type, 2025 VS 2032
  36. 7.10.3 Spain Human Blood Products Sales Value Share by Application, 2025 VS 2032
  37. 7.11 Russia
  38. 7.11.1 Russia Human Blood Products Sales Value Growth Rate (2021-2032)
  39. 7.11.2 Russia Human Blood Products Sales Value Share by Type, 2025 VS 2032
  40. 7.11.3 Russia Human Blood Products Sales Value Share by Application, 2025 VS 2032
  41. 7.12 Netherlands
  42. 7.12.1 Netherlands Human Blood Products Sales Value Growth Rate (2021-2032)
  43. 7.12.2 Netherlands Human Blood Products Sales Value Share by Type, 2025 VS 2032
  44. 7.12.3 Netherlands Human Blood Products Sales Value Share by Application, 2025 VS 2032
  45. 7.13 Nordic Countries
  46. 7.13.1 Nordic Countries Human Blood Products Sales Value Growth Rate (2021-2032)
  47. 7.13.2 Nordic Countries Human Blood Products Sales Value Share by Type, 2025 VS 2032
  48. 7.13.3 Nordic Countries Human Blood Products Sales Value Share by Application, 2025 VS 2032
  49. 7.14 China
  50. 7.14.1 China Human Blood Products Sales Value Growth Rate (2021-2032)
  51. 7.14.2 China Human Blood Products Sales Value Share by Type, 2025 VS 2032
  52. 7.14.3 China Human Blood Products Sales Value Share by Application, 2025 VS 2032
  53. 7.15 Japan
  54. 7.15.1 Japan Human Blood Products Sales Value Growth Rate (2021-2032)
  55. 7.15.2 Japan Human Blood Products Sales Value Share by Type, 2025 VS 2032
  56. 7.15.3 Japan Human Blood Products Sales Value Share by Application, 2025 VS 2032
  57. 7.16 South Korea
  58. 7.16.1 South Korea Human Blood Products Sales Value Growth Rate (2021-2032)
  59. 7.16.2 South Korea Human Blood Products Sales Value Share by Type, 2025 VS 2032
  60. 7.16.3 South Korea Human Blood Products Sales Value Share by Application, 2025 VS 2032
  61. 7.17 India
  62. 7.17.1 India Human Blood Products Sales Value Growth Rate (2021-2032)
  63. 7.17.2 India Human Blood Products Sales Value Share by Type, 2025 VS 2032
  64. 7.17.3 India Human Blood Products Sales Value Share by Application, 2025 VS 2032
  65. 7.18 Australia
  66. 7.18.1 Australia Human Blood Products Sales Value Growth Rate (2021-2032)
  67. 7.18.2 Australia Human Blood Products Sales Value Share by Type, 2025 VS 2032
  68. 7.18.3 Australia Human Blood Products Sales Value Share by Application, 2025 VS 2032
  69. 7.19 Southeast Asia
  70. 7.19.1 Southeast Asia Human Blood Products Sales Value Growth Rate (2021-2032)
  71. 7.19.2 Southeast Asia Human Blood Products Sales Value Share by Type, 2025 VS 2032
  72. 7.19.3 Southeast Asia Human Blood Products Sales Value Share by Application, 2025 VS 2032
  73. 7.20 Brazil
  74. 7.20.1 Brazil Human Blood Products Sales Value Growth Rate (2021-2032)
  75. 7.20.2 Brazil Human Blood Products Sales Value Share by Type, 2025 VS 2032
  76. 7.20.3 Brazil Human Blood Products Sales Value Share by Application, 2025 VS 2032
  77. 7.21 Argentina
  78. 7.21.1 Argentina Human Blood Products Sales Value Growth Rate (2021-2032)
  79. 7.21.2 Argentina Human Blood Products Sales Value Share by Type, 2025 VS 2032
  80. 7.21.3 Argentina Human Blood Products Sales Value Share by Application, 2025 VS 2032
  81. 7.22 Chile
  82. 7.22.1 Chile Human Blood Products Sales Value Growth Rate (2021-2032)
  83. 7.22.2 Chile Human Blood Products Sales Value Share by Type, 2025 VS 2032
  84. 7.22.3 Chile Human Blood Products Sales Value Share by Application, 2025 VS 2032
  85. 7.23 Colombia
  86. 7.23.1 Colombia Human Blood Products Sales Value Growth Rate (2021-2032)
  87. 7.23.2 Colombia Human Blood Products Sales Value Share by Type, 2025 VS 2032
  88. 7.23.3 Colombia Human Blood Products Sales Value Share by Application, 2025 VS 2032
  89. 7.24 Peru
  90. 7.24.1 Peru Human Blood Products Sales Value Growth Rate (2021-2032)
  91. 7.24.2 Peru Human Blood Products Sales Value Share by Type, 2025 VS 2032
  92. 7.24.3 Peru Human Blood Products Sales Value Share by Application, 2025 VS 2032
  93. 7.25 Saudi Arabia
  94. 7.25.1 Saudi Arabia Human Blood Products Sales Value Growth Rate (2021-2032)
  95. 7.25.2 Saudi Arabia Human Blood Products Sales Value Share by Type, 2025 VS 2032
  96. 7.25.3 Saudi Arabia Human Blood Products Sales Value Share by Application, 2025 VS 2032
  97. 7.26 Israel
  98. 7.26.1 Israel Human Blood Products Sales Value Growth Rate (2021-2032)
  99. 7.26.2 Israel Human Blood Products Sales Value Share by Type, 2025 VS 2032
  100. 7.26.3 Israel Human Blood Products Sales Value Share by Application, 2025 VS 2032
  101. 7.27 UAE
  102. 7.27.1 UAE Human Blood Products Sales Value Growth Rate (2021-2032)
  103. 7.27.2 UAE Human Blood Products Sales Value Share by Type, 2025 VS 2032
  104. 7.27.3 UAE Human Blood Products Sales Value Share by Application, 2025 VS 2032
  105. 7.28 Turkey
  106. 7.28.1 Turkey Human Blood Products Sales Value Growth Rate (2021-2032)
  107. 7.28.2 Turkey Human Blood Products Sales Value Share by Type, 2025 VS 2032
  108. 7.28.3 Turkey Human Blood Products Sales Value Share by Application, 2025 VS 2032
  109. 7.29 Iran
  110. 7.29.1 Iran Human Blood Products Sales Value Growth Rate (2021-2032)
  111. 7.29.2 Iran Human Blood Products Sales Value Share by Type, 2025 VS 2032
  112. 7.29.3 Iran Human Blood Products Sales Value Share by Application, 2025 VS 2032
  113. 7.30 Egypt
  114. 7.30.1 Egypt Human Blood Products Sales Value Growth Rate (2021-2032)
  115. 7.30.2 Egypt Human Blood Products Sales Value Share by Type, 2025 VS 2032
  116. 7.30.3 Egypt Human Blood Products Sales Value Share by Application, 2025 VS 2032
8 Company Profiles
  1. 8.1 Biotest
  2. 8.1.1 Biotest Company Information
  3. 8.1.2 Biotest Business Overview
  4. 8.1.3 Biotest Human Blood Products Revenue and Gross Margin (2021-2026)
  5. 8.1.4 Biotest Human Blood Products Product Portfolio
  6. 8.1.5 Biotest Recent Developments
  7. 8.2 BPL
  8. 8.2.1 BPL Company Information
  9. 8.2.2 BPL Business Overview
  10. 8.2.3 BPL Human Blood Products Revenue and Gross Margin (2021-2026)
  11. 8.2.4 BPL Human Blood Products Product Portfolio
  12. 8.2.5 BPL Recent Developments
  13. 8.3 CSL
  14. 8.3.1 CSL Company Information
  15. 8.3.2 CSL Business Overview
  16. 8.3.3 CSL Human Blood Products Revenue and Gross Margin (2021-2026)
  17. 8.3.4 CSL Human Blood Products Product Portfolio
  18. 8.3.5 CSL Recent Developments
  19. 8.4 Grifols
  20. 8.4.1 Grifols Company Information
  21. 8.4.2 Grifols Business Overview
  22. 8.4.3 Grifols Human Blood Products Revenue and Gross Margin (2021-2026)
  23. 8.4.4 Grifols Human Blood Products Product Portfolio
  24. 8.4.5 Grifols Recent Developments
  25. 8.5 Kedrion
  26. 8.5.1 Kedrion Company Information
  27. 8.5.2 Kedrion Business Overview
  28. 8.5.3 Kedrion Human Blood Products Revenue and Gross Margin (2021-2026)
  29. 8.5.4 Kedrion Human Blood Products Product Portfolio
  30. 8.5.5 Kedrion Recent Developments
  31. 8.6 KM Biologics
  32. 8.6.1 KM Biologics Company Information
  33. 8.6.2 KM Biologics Business Overview
  34. 8.6.3 KM Biologics Human Blood Products Revenue and Gross Margin (2021-2026)
  35. 8.6.4 KM Biologics Human Blood Products Product Portfolio
  36. 8.6.5 KM Biologics Recent Developments
  37. 8.7 LFB Group
  38. 8.7.1 LFB Group Company Information
  39. 8.7.2 LFB Group Business Overview
  40. 8.7.3 LFB Group Human Blood Products Revenue and Gross Margin (2021-2026)
  41. 8.7.4 LFB Group Human Blood Products Product Portfolio
  42. 8.7.5 LFB Group Recent Developments
  43. 8.8 Octapharma
  44. 8.8.1 Octapharma Company Information
  45. 8.8.2 Octapharma Business Overview
  46. 8.8.3 Octapharma Human Blood Products Revenue and Gross Margin (2021-2026)
  47. 8.8.4 Octapharma Human Blood Products Product Portfolio
  48. 8.8.5 Octapharma Recent Developments
  49. 8.9 Boya Bio
  50. 8.9.1 Boya Bio Company Information
  51. 8.9.2 Boya Bio Business Overview
  52. 8.9.3 Boya Bio Human Blood Products Revenue and Gross Margin (2021-2026)
  53. 8.9.4 Boya Bio Human Blood Products Product Portfolio
  54. 8.9.5 Boya Bio Recent Developments
  55. 8.10 Hualan Bio
  56. 8.10.1 Hualan Bio Company Information
  57. 8.10.2 Hualan Bio Business Overview
  58. 8.10.3 Hualan Bio Human Blood Products Revenue and Gross Margin (2021-2026)
  59. 8.10.4 Hualan Bio Human Blood Products Product Portfolio
  60. 8.10.5 Hualan Bio Recent Developments
  61. 8.11 Nanyue Bio
  62. 8.11.1 Nanyue Bio Company Information
  63. 8.11.2 Nanyue Bio Business Overview
  64. 8.11.3 Nanyue Bio Human Blood Products Revenue and Gross Margin (2021-2026)
  65. 8.11.4 Nanyue Bio Human Blood Products Product Portfolio
  66. 8.11.5 Nanyue Bio Recent Developments
  67. 8.12 RAAS
  68. 8.12.1 RAAS Company Information
  69. 8.12.2 RAAS Business Overview
  70. 8.12.3 RAAS Human Blood Products Revenue and Gross Margin (2021-2026)
  71. 8.12.4 RAAS Human Blood Products Product Portfolio
  72. 8.12.5 RAAS Recent Developments
  73. 8.13 Shuanglin Bio
  74. 8.13.1 Shuanglin Bio Company Information
  75. 8.13.2 Shuanglin Bio Business Overview
  76. 8.13.3 Shuanglin Bio Human Blood Products Revenue and Gross Margin (2021-2026)
  77. 8.13.4 Shuanglin Bio Human Blood Products Product Portfolio
  78. 8.13.5 Shuanglin Bio Recent Developments
  79. 8.14 CBPO
  80. 8.14.1 CBPO Company Information
  81. 8.14.2 CBPO Business Overview
  82. 8.14.3 CBPO Human Blood Products Revenue and Gross Margin (2021-2026)
  83. 8.14.4 CBPO Human Blood Products Product Portfolio
  84. 8.14.5 CBPO Recent Developments
  85. 8.15 Tiantan Bio
  86. 8.15.1 Tiantan Bio Company Information
  87. 8.15.2 Tiantan Bio Business Overview
  88. 8.15.3 Tiantan Bio Human Blood Products Revenue and Gross Margin (2021-2026)
  89. 8.15.4 Tiantan Bio Human Blood Products Product Portfolio
  90. 8.15.5 Tiantan Bio Recent Developments
  91. 8.16 Weiguang Bio
  92. 8.16.1 Weiguang Bio Company Information
  93. 8.16.2 Weiguang Bio Business Overview
  94. 8.16.3 Weiguang Bio Human Blood Products Revenue and Gross Margin (2021-2026)
  95. 8.16.4 Weiguang Bio Human Blood Products Product Portfolio
  96. 8.16.5 Weiguang Bio Recent Developments
  97. 8.17 Takeda
  98. 8.17.1 Takeda Company Information
  99. 8.17.2 Takeda Business Overview
  100. 8.17.3 Takeda Human Blood Products Revenue and Gross Margin (2021-2026)
  101. 8.17.4 Takeda Human Blood Products Product Portfolio
  102. 8.17.5 Takeda Recent Developments
  103. 8.18 Yuanda Shuyang
  104. 8.18.1 Yuanda Shuyang Company Information
  105. 8.18.2 Yuanda Shuyang Business Overview
  106. 8.18.3 Yuanda Shuyang Human Blood Products Revenue and Gross Margin (2021-2026)
  107. 8.18.4 Yuanda Shuyang Human Blood Products Product Portfolio
  108. 8.18.5 Yuanda Shuyang Recent Developments
9 Concluding Insights
    10 Appendix
    1. 10.1 Reasons for Doing This Study
    2. 10.2 Research Methodology
    3. 10.3 Research Process
    4. 10.4 Authors List of This Report
    5. 10.5 Data Source
    6. 10.5.1 Secondary Sources
    7. 10.5.2 Primary Sources

    GET THE RESEARCH

    Choose your license.

    Choose who needs access.
    All options are for this report and research series.

    Compare access permissions.

    Single User License
    One named user. Individual access.
    Multi User License
    Up to 5 users in the same department.
    Enterprise License
    Organization-wide access within the agreed license.

    Access applies to the purchased edition. Later editions are separate purchases.

    License options
    $4,250USD
    Buy now

    PDF by email within 3–5 working days after payment confirmation.

    Talk to an analyst
    APO Research, Inc.
    Talk to an analyst